Request Deal Involvement

New Rhein Healthcare Investors, Andera Partners and Omega Funds led a $160m Series A round in Alveus Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Gorrissen Federspiel

legal advisors

Gorrissen Federspiel

Damouni Group

pr advisors

Damouni Group

Meru Advisors

pr advisors

Meru Advisors

Gorrissen Federspiel

legal advisors

Gorrissen Federspiel

or

Principals

SANOFI SA

bidder

SANOFI SA

OMEGA FUNDS

bidder

OMEGA FUNDS

KURMA PARTNERS

bidder

KURMA PARTNERS

NEW RHEIN HEALTHCARE INVESTORS LLC

bidder

NEW RHEIN HEALTHCARE INVESTORS LLC

ALVEUS THERAUPETICS INC

target

ALVEUS THERAUPETICS INC

ANDERA PARTNERS

bidder

ANDERA PARTNERS

AVEGO BIOSCIENCE CAPITAL

bidder

AVEGO BIOSCIENCE CAPITAL

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2026 Datasite

MergerLinks - Request Credit - New Rhein Healthcare Investors, Andera Partners and Omega Funds led a $160m Series A round in Alveus Therapeutics.